Nathalie Compagnone
Directeur Général chez Innovative Concepts in Drug Development SAS
Profil
Nathalie Compagnone is the founder and currently holds the position of Chief Executive & Scientific Officer at Innovative Concepts in Drug Development SAS, which she founded in 2007.
She previously worked as Head-Laboratory at The University of California, San Francisco and as Principal at Trophos SA. Dr. Compagnone holds an MBA degree from Rutgers State University of New Jersey and an undergraduate degree from Université de Franche-Comté.
Postes actifs de Nathalie Compagnone
| Sociétés | Poste | Début |
|---|---|---|
Innovative Concepts in Drug Development SAS
 Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Directeur Général | 01/01/2007 |
Anciens postes connus de Nathalie Compagnone
| Sociétés | Poste | Fin |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Formation de Nathalie Compagnone
| Rutgers State University of New Jersey | Masters Business Admin |
| Université de Franche-Comté | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |
